These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 429120)

  • 21. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
    Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma testosterone: a sound criterion of the effectiveness of hormonal treatment of prostatic carcinoma].
    Maleeva A; Tsvetkov M; Kekhaĭova M
    Vutr Boles; 1980; 19(3):42-6. PubMed ID: 6771918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
    Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
    Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 27. Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
    Dunzendorfer U; Drahovsky D
    Arzneimittelforschung; 1978; 28(6):1027-30. PubMed ID: 86358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of orchidectomy or oestrogen treatment on serum levels of pregnancy associated alpha 2-glycoprotein and sex hormone binding globulin in patients with prostatic cancer.
    Carlström K; Eriksson A; Gustafsson SA; Henriksson P; Pousette A; Stege R; von Schoultz B
    Int J Androl; 1985 Feb; 8(1):21-7. PubMed ID: 3922901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal changes after localized prostate cancer treatment. Comparison between external beam radiation therapy and radical prostatectomy.
    Planas J; Celma A; Placer J; Maldonado X; Trilla E; Salvador C; Lorente D; Regis L; Cuadras M; Carles J; Morote J
    Actas Urol Esp; 2016 Nov; 40(9):549-555. PubMed ID: 27207596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormonal changes in carcinoma of the prostate].
    Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
    Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostatic cancer.
    Blacklock NJ
    Urol Res; 1977; 5(1):1-5. PubMed ID: 324081
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
    Harper ME; Peeling WB; Cowley T; Brownsey BG; Phillips ME; Groom G; Fahmy DR; Griffiths K
    Acta Endocrinol (Copenh); 1976 Feb; 81(2):409-26. PubMed ID: 946155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of chlorotrianisene (Tace) of kinetics of 3H-testosterone metabolism in patients with carcinoma of the prostate.
    Baba S; Janetschek G; Pollow K; Hahn K; Jacobi GH
    Br J Urol; 1982 Aug; 54(4):393-8. PubMed ID: 6810984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum FSH, LH and prolactin in normal males and patients with prostatic diseases.
    Hammond GL; Kontturi M; Määttälä P; Puukka M; Vihko R
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):129-35. PubMed ID: 70287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
    Madersbacher S; Schatzl G; Bieglmayer C; Reiter WJ; Gassner C; Berger P; Zidek T; Marberger M
    Urology; 2002 Nov; 60(5):869-74. PubMed ID: 12429318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate.
    Grigsby PW; Perez CA
    J Urol; 1986 Apr; 135(4):726-7. PubMed ID: 3083117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of total and subcapsular orchidectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of the prostate.
    Bergman B; Damber JE; Tomić R
    Urol Int; 1982; 37(2):139-44. PubMed ID: 6810527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine effects of high-dose ketoconazole therapy in advanced prostatic cancer.
    Heyns W; Drochmans A; van der Schueren E; Verhoeven G
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):276-83. PubMed ID: 3933237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolactin.
    Jacobi GH; Sinterhauf K; Kurth KH; Altwein JE
    Urol Res; 1978; 6(3):159-65. PubMed ID: 758043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular endocrine function after withdrawal of oestrogen treatment in patients with carcinoma of the prostate.
    Tomić R; Bergman B; Damber JE
    Br J Urol; 1983 Feb; 55(1):42-7. PubMed ID: 6402048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.